Veterinary Pharmacovigilance Industry Forecast to Hit $1.48 Billion by 2029 With a Strong 12.9% CAGR
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The Veterinary Pharmacovigilance Market Covering 2025–2034?
The veterinary pharmacovigilance market has seen significant growth in recent years. It is projected to expand from $0.81 billion in 2024 to $0.91 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 13.1%. The historical factors contributing to this expansion include a heightened awareness of animal health, an increase in the companion animal population, a rising demand for livestock products, the broadening of veterinary services, and a greater occurrence of zoonotic diseases.
The veterinary pharmacovigilance market is projected to experience substantial growth over the next few years. It is expected to expand to $1.48 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.9%. This expansion during the forecast period is driven by factors such as increasing pet ownership and associated spending, rising veterinary expenditures, a heightened emphasis on animal welfare, the broadening scope of telemedicine in veterinary services, and a greater demand for personalized veterinary care. Significant trends anticipated during this period include the adoption of digital reporting systems, the expansion of telehealth services for veterinary care, the integration of blockchain for data security, and the development of cloud-based pharmacovigilance platforms.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21002&type=smp
Which Drivers Are Shaping The Veterinary Pharmacovigilance Industry’s Market Share?
The increasing need for animal health and medicinal items is anticipated to fuel the expansion of the veterinary pharmacovigilance market in the future. These products encompass items such as food, medications, and grooming supplies, all intended to preserve the well-being of companion animals. This escalating demand stems from factors like increased pet ownership, progress in veterinary medical practices, and the imperative for enhanced livestock output. Furthermore, greater consciousness regarding animal welfare and a rise in animal disease occurrences also contribute to this heightened demand. In the context of pet care, veterinary pharmacovigilance plays a crucial role in guaranteeing the safety and effectiveness of pet medications through constant monitoring and evaluation of potential adverse reactions, alongside ensuring adherence to regulatory standards. For example, data from March 2024, provided by the Republic of Estonia’s Agency of Medicines (Ravimiamet), Estonia’s national regulatory body, revealed that the veterinary medicinal products sector experienced a 6.9% increase in 2023, growing to 18.6 million euros from 17.4 million euros in 2022. Consequently, the expanding need for animal health and medicinal products will be a key driver for the growth of the veterinary pharmacovigilance market.
What Are The Leading Segments Analyzed In The Veterinary Pharmacovigilance Market?
The veterinary pharmacovigilance market covered in this report is segmented –
1) By Type: In House, Outsourced
2) By Solution: Software, Services
3) By Product: Biologics, Anti Infectives, Other Products
4) By Animal Type: Companion Animals, Livestock Animals, Other Animal Types
5) By End User: Veterinary Hospitals, Veterinary Companies, Academic And Research Institutes
Subsegments:
1) By In House: Internal Pharmacovigilance Departments, In-House Monitoring And Reporting Systems, Veterinary Adverse Event Management Software
2) By Outsourced: Third-Party Pharmacovigilance Services, Contract Research Organizations (CROs) For Pharmacovigilance, Pharmacovigilance Consulting And Support Services
How Are Emerging Market Trends Shaping The Veterinary Pharmacovigilance Industry Landscape?
Leading companies within the veterinary pharmacovigilance market are concentrating on enhancing regulatory frameworks through advancements in data analytics, particularly in areas like adverse event reporting (REAS) and the creation of safety reports, all aimed at guaranteeing the secure and effective application of veterinary drugs. These processes, including adverse event reporting (REAS) and safety report preparation, entail recording and examining detrimental responses to veterinary medications to evaluate their safety profiles and uphold adherence to regulatory requirements. As an illustration, in August 2024, the Ministry of Agriculture and Rural Development, a governmental body situated in Mexico, introduced a new veterinary pharmacovigilance system. This Veterinary Pharmacovigilance System serves as a monitoring instrument created by SENASICA, designed to uphold the safety, quality, and efficacy of veterinary drugs throughout Mexico. The system gathers information regarding adverse reactions from various administrators of veterinary products, such as pharmaceutical firms, distributors, veterinary hospitals, and veterinarians, with the purpose of identifying, evaluating, and reducing the risks linked to these medicines. Additionally, the system incorporates the veterinary pharmacovigilance guide (REAS) to facilitate the documentation of adverse reactions and to oversee aspects like drug efficacy, residue thresholds, and environmental concerns.
Which Key Market Players Are Investing In Expansion And Innovation Of Veterinary Pharmacovigilance Market?
Major companies operating in the veterinary pharmacovigilance market are Accenture PLC, Zoetis Inc, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Covetrus Inc, IDEXX Laboratories, Inc., Ceva Santé Animale, Virbac SA, Merck Animal Health, Huvepharma EOOD, Norbrook Laboratories Ltd, ProPharma Group, ArisGlobal LLC, PQE Group, Chanelle Pharma Group Ltd, Clinvet International, Ennov SAS, Sarjen Systems Pvt. Ltd, PharSafer Associates Ltd, Medfiles Oy, Azierta Contract Science Support Consulting, Knoell Germany GmbH, Triveritas Ltd, Leon Research, Biologit, Indivirtus Group
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/veterinary-pharmacovigilance-global-market-report
Which Regional Markets Are Contributing Most To The Veterinary Pharmacovigilance Industry Expansion?
North America was the largest region in the veterinary pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Veterinary Pharmacovigilance Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21002&type=smp
Browse Through More Reports Similar to the Global Veterinary Pharmacovigilance Market 2025, By The Business Research Company
Veterinary Medical Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-medical-equipment-global-market-report
Veterinary Anesthesia Equipment Global Market Report 2025
Veterinary Patient Monitoring Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
